vs
Ecovyst Inc.（ECVT）与和黄医药（HCM）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是Ecovyst Inc.的1.4倍（$270.8M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs -16.5%），Ecovyst Inc.自由现金流更多（$22.9M vs $3.4M）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
ECVT vs HCM — 直观对比
营收规模更大
HCM
是对方的1.4倍
$199.4M
营收增速更快
ECVT
高出50.5%
-16.5%
自由现金流更多
ECVT
多$19.6M
$3.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $270.8M |
| 净利润 | — | $2.0M |
| 毛利率 | 23.4% | 37.7% |
| 营业利润率 | 10.9% | -13.2% |
| 净利率 | — | 0.7% |
| 营收同比 | 34.0% | -16.5% |
| 净利润同比 | — | -83.6% |
| 每股收益（稀释后） | $0.06 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTHCM
| Q4 25 | $199.4M | $270.8M | ||
| Q3 25 | $204.9M | — | ||
| Q2 25 | $176.1M | $277.7M | ||
| Q1 25 | $143.1M | $324.5M | ||
| Q4 24 | $148.9M | — | ||
| Q3 24 | $153.9M | — | ||
| Q2 24 | $154.0M | $305.7M | ||
| Q1 24 | $141.6M | — |
净利润ECVTHCM
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-79.3M | — | ||
| Q2 25 | $6.0M | $455.0M | ||
| Q1 25 | $-3.6M | $11.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.3M | — | ||
| Q2 24 | $8.3M | $25.8M | ||
| Q1 24 | $1.2M | — |
毛利率ECVTHCM
| Q4 25 | 23.4% | 37.7% | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 22.8% | 0.1% | ||
| Q1 25 | 13.3% | 48.0% | ||
| Q4 24 | 28.9% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 27.3% | 41.1% | ||
| Q1 24 | 23.5% | — |
营业利润率ECVTHCM
| Q4 25 | 10.9% | -13.2% | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 9.0% | -1.3% | ||
| Q1 25 | -0.7% | -5.0% | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 14.1% | -9.0% | ||
| Q1 24 | 9.5% | — |
净利率ECVTHCM
| Q4 25 | — | 0.7% | ||
| Q3 25 | -38.7% | — | ||
| Q2 25 | 3.4% | 163.8% | ||
| Q1 25 | -2.5% | 3.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 5.4% | 8.4% | ||
| Q1 24 | 0.9% | — |
每股收益（稀释后）ECVTHCM
| Q4 25 | $0.06 | $0.00 | ||
| Q3 25 | $-0.69 | — | ||
| Q2 25 | $0.05 | $0.52 | ||
| Q1 25 | $-0.03 | $0.01 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.07 | $0.03 | ||
| Q1 24 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $1.4B |
| 总债务越低越好 | $392.6M | $93.2M |
| 股东权益账面价值 | $603.4M | $1.2B |
| 总资产 | $1.3B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.65× | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ECVTHCM
| Q4 25 | $197.2M | $1.4B | ||
| Q3 25 | $82.0M | — | ||
| Q2 25 | $69.6M | $1.4B | ||
| Q1 25 | $127.5M | $836.1M | ||
| Q4 24 | $131.4M | — | ||
| Q3 24 | $123.5M | — | ||
| Q2 24 | $83.3M | $802.5M | ||
| Q1 24 | $103.1M | — |
总债务ECVTHCM
| Q4 25 | $392.6M | $93.2M | ||
| Q3 25 | $854.8M | — | ||
| Q2 25 | $856.6M | $93.4M | ||
| Q1 25 | $859.0M | $82.8M | ||
| Q4 24 | $860.8M | — | ||
| Q3 24 | $862.7M | — | ||
| Q2 24 | $862.4M | $82.1M | ||
| Q1 24 | $866.2M | — |
股东权益ECVTHCM
| Q4 25 | $603.4M | $1.2B | ||
| Q3 25 | $607.9M | — | ||
| Q2 25 | $692.4M | $1.2B | ||
| Q1 25 | $698.7M | $759.9M | ||
| Q4 24 | $700.5M | — | ||
| Q3 24 | $729.4M | — | ||
| Q2 24 | $717.3M | $740.1M | ||
| Q1 24 | $711.4M | — |
总资产ECVTHCM
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | $1.8B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.8B | $1.3B | ||
| Q1 24 | $1.8B | — |
负债/权益比ECVTHCM
| Q4 25 | 0.65× | 0.08× | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.24× | 0.08× | ||
| Q1 25 | 1.23× | 0.11× | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.20× | 0.11× | ||
| Q1 24 | 1.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $3.4M |
| 自由现金流率自由现金流/营收 | 11.5% | 1.2% |
| 资本支出强度资本支出/营收 | 9.4% | 1.8% |
| 现金转化率经营现金流/净利润 | — | 4.21× |
| 过去12个月自由现金流最近4个季度 | $69.9M | $-96.2M |
8季度趋势，按日历期对齐
经营现金流ECVTHCM
| Q4 25 | $41.8M | $8.2M | ||
| Q3 25 | $55.3M | — | ||
| Q2 25 | $33.0M | $-72.9M | ||
| Q1 25 | $10.3M | $40.3M | ||
| Q4 24 | $43.5M | — | ||
| Q3 24 | $59.9M | — | ||
| Q2 24 | $10.0M | $-39.8M | ||
| Q1 24 | $36.5M | — |
自由现金流ECVTHCM
| Q4 25 | $22.9M | $3.4M | ||
| Q3 25 | $53.2M | — | ||
| Q2 25 | $7.8M | $-82.2M | ||
| Q1 25 | $-14.0M | $32.5M | ||
| Q4 24 | $30.9M | — | ||
| Q3 24 | $53.6M | — | ||
| Q2 24 | $-9.3M | $-49.9M | ||
| Q1 24 | $19.1M | — |
自由现金流率ECVTHCM
| Q4 25 | 11.5% | 1.2% | ||
| Q3 25 | 26.0% | — | ||
| Q2 25 | 4.4% | -29.6% | ||
| Q1 25 | -9.8% | 10.0% | ||
| Q4 24 | 20.7% | — | ||
| Q3 24 | 34.9% | — | ||
| Q2 24 | -6.1% | -16.3% | ||
| Q1 24 | 13.5% | — |
资本支出强度ECVTHCM
| Q4 25 | 9.4% | 1.8% | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 14.4% | 3.3% | ||
| Q1 25 | 16.9% | 2.4% | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 12.5% | 3.3% | ||
| Q1 24 | 12.3% | — |
现金转化率ECVTHCM
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.52× | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.21× | — | ||
| Q2 24 | 1.20× | -1.54× | ||
| Q1 24 | 29.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
HCM
暂无分部数据
